|
NAV1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.832650E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.570600E-04 |
| Normal-vs-Stage2 |
1.757690E-02 |
| Normal-vs-Stage3 |
3.656100E-02 |
| Normal-vs-Stage4 |
7.582400E-02 |
| Stage1-vs-Stage2 |
4.925200E-01 |
| Stage1-vs-Stage3 |
1.821630E-01 |
| Stage1-vs-Stage4 |
5.418400E-01 |
| Stage2-vs-Stage3 |
1.862000E-01 |
| Stage2-vs-Stage4 |
3.023200E-01 |
| Stage3-vs-Stage4 |
7.885000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.01310000000188E-05 |
| Normal-vs-AfricanAmerican |
1.120760E-01 |
| Normal-vs-Asian |
4.899400E-01 |
| Caucasian-vs-AfricanAmerican |
9.905400E-01 |
| Caucasian-vs-Asian |
9.024600E-03 |
| AfricanAmerican-vs-Asian |
2.247600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.943900E-03 |
| Normal-vs-Female |
1.993700E-04 |
| Male-vs-Female |
3.441800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.210900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.455100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.443700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.114200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.511000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.344800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.333600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.475400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.909190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.079800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.410140E-02 |
| Classical-VS-Follicular |
2.796600E-03 |
| Classical-VS-Other |
1.155220E-01 |
| Classical-VS-Normal |
1.17320000003751E-06 |
| Tall-VS-Follicular |
9.936600E-01 |
| Tall-VS-Other |
4.306000E-01 |
| Tall-VS-Normal |
5.313600E-01 |
| Follicular-VS-Other |
5.037600E-01 |
| Follicular-VS-Normal |
4.440000E-01 |
| Other-VS-Normal |
5.223200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.159200E-03 |
| Normal-vs-N1 |
1.901650E-01 |
| N0-vs-N1 |
2.051600E-01 |
|
|
